Oxytocin to improve bone health in children with autism
Part of Mental health clinical trials.
This Phase 2 study tests whether oxytocin can help improve bone health in children and teens with autism spectrum disorder. It also checks safety by monitoring symptoms and doing blood tests and imaging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 and 18 years old when the study starts
- A clinician has diagnosed autism spectrum disorder (ASD)
- Your body weight is not too low (BMI is at least the 5th percentile)
- A parent or legal guardian can sign consent and join study visits
- You must avoid certain conditions or syndromes that can affect bones or heart health
- You must not take certain bone-affecting medicines besides calcium or vitamin D
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether a nasal spray containing oxytocin can help youth with autism spectrum disorder. It focuses on participants who are healthy enough for the spray and able to follow study instructions, and it avoids people with certain nasal problems or allergies.
This trial studies whether oxytocin, given alongside structured psycho-educational support, can be safe and feasible in helping children with autism and moderate-to-severe intellectual disability who have challenging behaviors. It focuses on whether the added treatment can work without unacceptable side effects.
This study tests whether a drug called MDMA changes oxytocin levels (a hormone related to social bonding) differently in autistic adults compared to non-autistic adults. Researchers want to understand if MDMA might help with social challenges some autistic people experience.
This study observes how intranasal insulin (a form of insulin delivered through the nose) affects children and young adults with autism spectrum disorder who are already using or planning to use it as part of their regular care. Researchers will track changes in behavior and social skills over about 6 months.
This Phase 2 study tests whether a single dose of N-acetylcysteine can improve “restricted and repetitive behaviors” in children with autism. It’s meant for kids who are stable and still in early puberty stages.
This study tests a therapy to help young children with autism who also have anxiety. The goal is to reduce anxious behaviors and improve daily life.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.